A detailed history of Blb&B Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Blb&B Advisors, LLC holds 527 shares of VRTX stock, worth $215,110. This represents 0.01% of its overall portfolio holdings.

Number of Shares
527
Previous 427 23.42%
Holding current value
$215,110
Previous $200,000 22.5%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$460.0 - $505.78 $46,000 - $50,578
100 Added 23.42%
527 $245,000
Q2 2024

Jul 26, 2024

BUY
$392.81 - $485.53 $167,729 - $207,321
427 New
427 $200,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.